CytoMed Therapeutics Limited (NASDAQ: GDTC) Stock Information | RedChip

CytoMed Therapeutics Limited (NASDAQ: GDTC)


$2.4100
+0.0400 ( -1.94% ) 1.7K

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Market Data


Open


$2.4100

Previous close


$2.3700

Volume


1.7K

Market cap


$29.54M

Day range


$2.4000 - $2.5240

52 week range


$1.2000 - $5.5000

SEC Filings


Form Type Description Pages Date
20-f Annual reports 181 Apr 22, 2024
6-k Form 6-K 3 Mar 18, 2024
6-k Form 6-K 3 Mar 04, 2024
6-k Form 6-K 3 Jan 29, 2024

Latest News